Biotechnology and Its Applications Notes

Overview

This chapter explains how recombinant DNA technology is applied for human welfare. In agriculture, biotechnology produces genetically modified crops with pest resistance, herbicide tolerance, improved nutrition and better yield. In medicine, it enables recombinant therapeutic proteins such as insulin, vaccines and highly sensitive molecular diagnosis using PCR and ELISA. Gene therapy aims to correct defective genes, with ADA deficiency as the classical NCERT example. Bt crops show how a bacterial toxin gene can protect plants from insect larvae. Transgenic animals help in studying diseases, producing biological products and testing vaccine or chemical safety. The chapter also stresses biosafety, bioethics, regulation and responsible use because genetically engineered organisms can affect health, environment and society.

Overview

Agricultural biotechnology uses genetic engineering to introduce desirable traits into crop plants. Genetically modified crops may resist insect pests, tolerate herbicides, survive environmental stress, improve nutritional quality or reduce post-harvest losses. NCERT emphasizes that GM plants can reduce dependence on chemical pesticides, increase crop yield and help create tailor-made plants for alternative resources. Pest-resistant crops often carry genes that produce proteins toxic to specific pests, while herbicide-tolerant crops allow weed control without killing the crop. Biofortification improves the nutritional value of food, such as increasing vitamins, minerals, proteins or healthier fats. For NEET, focus on purpose, examples, advantages, limitations and biosafety concerns linked with release of GM crops.

Overview

Medical biotechnology has transformed disease treatment, prevention and diagnosis. Recombinant DNA technology allows large-scale production of safe therapeutic proteins such as human insulin, which replaced animal-derived insulin and reduced allergic reactions. Vaccines can be produced using recombinant antigens or genetically engineered organisms, improving specificity and safety. Molecular diagnosis detects disease at an early stage by identifying nucleic acids, proteins or immune responses. PCR amplifies pathogen DNA or RNA-derived cDNA, making diagnosis possible even when pathogen number is low. ELISA uses antigen-antibody interaction to detect infections such as HIV or to measure biomolecules. NEET questions commonly test recombinant insulin production, PCR amplification logic, ELISA principle and early diagnosis advantages.

Overview

Gene therapy is a medical approach in which a functional gene is introduced into a patient’s cells to compensate for a defective or missing gene. The goal is to treat the genetic cause of disease rather than only symptoms. It may be somatic, affecting body cells and not inherited by offspring, or germ-line, affecting gametes or embryos and raising major ethical concerns. NCERT focuses on ADA deficiency, a disorder caused by absence of adenosine deaminase, essential for immune system function. In one approach, lymphocytes are taken from the patient, cultured, genetically corrected with functional ADA cDNA and returned to the patient. Because these cells are not immortal, repeated infusion may be needed unless bone marrow cells are corrected early.

Overview

Bt crops are genetically modified plants that carry insecticidal genes from the bacterium Bacillus thuringiensis. This bacterium produces crystal proteins called Cry proteins, which are toxic to specific insect larvae. In the bacterium, Bt toxin is produced as inactive protoxin. When an insect larva eats plant tissue containing the Bt protein, the alkaline gut activates the protoxin. The active toxin binds to epithelial cells of the midgut, creates pores, causes swelling and lysis, and eventually kills the insect. Bt cotton is the most important NCERT example and protects against bollworms. Different cry genes target different pests, making specificity a key NEET concept. Advantages include reduced insecticide use, but limitations include resistance development and biosafety concerns.

Overview

Transgenic animals are animals whose genome has been deliberately modified by introduction of a foreign gene. They are produced by inserting the desired DNA into embryos or reproductive cells, allowing the gene to integrate and express in the developing animal. NCERT emphasizes that over 95 percent of existing transgenic animals are mice, because they are easy to breed and useful as experimental models. Transgenic animals help study normal physiology, gene regulation, disease mechanisms and new treatments. They can act as disease models for human disorders, produce biological products such as therapeutic proteins, and help test vaccine safety or chemical toxicity. The famous NCERT example is Rosie, a transgenic cow that produced human protein-enriched milk containing alpha-lactalbumin.

Overview

Biosafety means the safe handling, testing and release of organisms or products developed using biotechnology, especially genetically engineered organisms. Bioethics deals with moral questions such as ownership of genetic resources, animal welfare, human gene modification, informed consent, patenting and social fairness. Genetic engineering can bring enormous benefits, but it also carries risks such as allergenicity, toxicity, gene transfer to wild relatives, harm to non-target organisms and development of resistant pests. Therefore, regulatory guidelines are essential before GM crops, recombinant medicines or transgenic animals are released or used. In India, GEAC is associated with approval of large-scale use and environmental release of genetically engineered organisms. NEET questions often test definitions, risks, ethical concerns and the need for regulation.